The Achondroplasia FGFR3 Full Gene Sequence Analysis Test is a specialized genetic test designed to identify mutations in the FGFR3 gene, which are responsible for achondroplasia, the most common form of dwarfism. This condition is characterized by a specific pattern of physical features and skeletal abnormalities, including shortened limbs and an enlarged head. The FGFR3 gene plays a crucial role in the development and maintenance of bone and tissue, and mutations in this gene disrupt normal growth patterns, leading to the characteristics associated with achondroplasia.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the entire sequence of the FGFR3 gene to pinpoint any mutations. This comprehensive approach ensures high accuracy in diagnosis, which is critical for understanding the condition, guiding treatment decisions, and offering genetic counseling for families. The cost of the test is 6000 AED, reflecting the advanced technology and expertise required to perform this intricate analysis.
This test is particularly valuable for prospective parents with a family history of achondroplasia, couples seeking genetic counseling, and individuals displaying symptoms related to the condition. By confirming the presence or absence of FGFR3 gene mutations, the test provides essential information for managing health and making informed decisions about care and family planning.
The Endocrine Cancer Gene Panel Test, offered at DNA Labs UAE for a cost of 7200 AED, is a comprehensive diagnostic tool designed to identify genetic mutations associated with various types of endocrine cancers. This cutting-edge test analyzes multiple genes simultaneously, providing a detailed genetic profile that can help in the early detection, diagnosis, and management of endocrine cancers, including thyroid, adrenal, and pituitary tumors.
By focusing on specific gene mutations known to be linked with endocrine cancers, the test enables healthcare providers to tailor treatment strategies to the individual patient, potentially improving outcomes and reducing the risk of unnecessary treatments. The results from this panel can also offer valuable information regarding prognosis and the risk of cancer recurrence, as well as help in identifying at-risk family members who may benefit from genetic counseling and testing.
Conducted at the state-of-the-art facilities of DNA Labs UAE, the test ensures accuracy, confidentiality, and support from a team of genetic experts, making it a crucial resource for patients and doctors in the fight against endocrine cancers.
The Familial Mediterranean Fever (FMF) MEFV Full Gene Analysis Test is a comprehensive genetic screening designed to identify mutations in the MEFV gene, which are associated with Familial Mediterranean Fever. This condition is an inherited disorder that primarily affects individuals of Mediterranean and Middle Eastern descent, leading to recurrent fevers and painful inflammation of the abdomen, lungs, and joints. By analyzing the entire MEFV gene, this test can provide crucial information for the diagnosis, management, and treatment planning of FMF.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability in results. The cost of the FMF MEFV Full Gene Analysis Test is 7200 AED, reflecting the comprehensive nature of the genetic analysis and the expertise required to interpret its findings. This test is particularly important for individuals with a family history of FMF or those exhibiting symptoms, as early detection can significantly improve the quality of life through targeted treatments and lifestyle adjustments.
The Gastrointestinal Cancer Gene Panel Test is a sophisticated diagnostic tool designed to identify specific genetic mutations associated with various types of gastrointestinal cancers, including cancers of the stomach, colon, rectum, esophagus, and pancreas. By analyzing a patient's DNA, this comprehensive test can detect alterations in multiple genes that are known to increase the risk of developing gastrointestinal cancers.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test offers a proactive approach for individuals with a family history of gastrointestinal cancers or those who want to assess their genetic predisposition to these diseases. The test cost is set at 7200 AED, reflecting the extensive analysis and detailed insights it provides. Results from this test can guide personalized prevention strategies, inform treatment decisions, and help in the early detection of cancers, significantly impacting patient outcomes.
The "Glioma Panel MGMT IDH1 and 2 FISH 1p19q Test" is a comprehensive diagnostic tool used in the field of oncology, specifically tailored for the assessment of gliomas, a type of tumor that occurs in the brain and spinal cord. This panel test is designed to analyze several genetic markers critical for the diagnosis, prognosis, and treatment planning of glioma cases.
The test focuses on the evaluation of:
- **MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation**: The methylation status of the MGMT gene is crucial for predicting the responsiveness of the tumor to alkylating agents, a common form of chemotherapy.
- **IDH1 and IDH2 mutations**: Mutations in the isocitrate dehydrogenase 1 and 2 genes are common in gliomas and are important prognostic factors. They can also influence treatment decisions.
- **FISH (Fluorescence In Situ Hybridization) for 1p19q co-deletion**: This test looks for the deletion of chromosomal arms 1p and 19q, which is associated with a better response to treatment and longer overall survival in patients with oligodendrogliomas, a subtype of glioma.
Conducted at DNA Labs UAE, a facility known for its advanced diagnostic technologies and expertise in genetic testing, this panel offers a crucial insight into the genetic makeup of gliomas. Understanding these genetic aspects allows healthcare providers to tailor a more effective and personalized treatment strategy for patients.
The cost of the Glioma Panel MGMT IDH1 and 2 FISH 1p19q Test is 7200 AED. Given the detailed genetic insights it provides, this test is a valuable investment for patients undergoing glioma treatment, potentially leading to more targeted therapies with better outcomes.
The Glycogen Storage Disorder (GSD) Gene Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect genetic mutations associated with various types of Glycogen Storage Disorders. GSDs are a group of inherited metabolic conditions that affect the body's ability to store and release glucose from glycogen, leading to a range of symptoms from mild to severe, including muscle weakness, liver dysfunction, and in some cases, life-threatening complications.
This gene panel test specifically targets the genes known to be associated with the different forms of GSD, making it an essential step in confirming a diagnosis, understanding the specific type of GSD, and guiding treatment strategies. The test involves analyzing the patient's DNA to identify mutations in the genes related to glycogen storage and metabolism.
At DNA Labs UAE, the Glycogen Storage Disorder Gene Panel Test is priced at 7200 AED. The test process is streamlined and conducted by experienced professionals, ensuring accuracy and reliability in the results. Once the test is completed, genetic counselors at DNA Labs UAE can provide valuable insights into the implications of the test results, potential treatments, and management strategies for individuals diagnosed with a Glycogen Storage Disorder.
The Haemophilia A and B Gene Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the genes responsible for haemophilia A and B. Haemophilia A, also known as classic haemophilia, is primarily caused by mutations in the F8 gene, leading to a deficiency in clotting factor VIII. Haemophilia B, on the other hand, results from mutations in the F9 gene, which causes a deficiency in clotting factor IX. Both conditions are inherited in an X-linked recessive pattern, predominantly affecting males.
This gene panel test is a crucial step in diagnosing these bleeding disorders, enabling healthcare providers to make informed decisions regarding treatment plans and management strategies. It involves analyzing the patient's DNA to identify any genetic mutations associated with haemophilia A and B, offering a high degree of accuracy and specificity.
Priced at 7200 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring quality and reliability. The cost reflects the comprehensive nature of the test, covering a detailed analysis that can guide patient care and inform family planning decisions for those affected by or carriers of haemophilia. By opting for this test, patients and their families gain valuable insights into their genetic makeup, empowering them with information crucial for managing the condition effectively.
The HBOC Extended Panel Hereditary Breast and Ovarian Cancer 32 Genes Test is a comprehensive genetic screening designed to identify mutations across 32 genes associated with an increased risk of developing hereditary breast and ovarian cancer. This advanced test, available at DNA Labs UAE, serves as a crucial tool for individuals with a family history of these cancers, enabling them to take proactive steps in managing their health. The test is meticulously designed to provide a thorough genetic risk assessment, offering insights that can guide personalized prevention and surveillance strategies. By analyzing a wide array of genes beyond the well-known BRCA1 and BRCA2, the test ensures a more comprehensive understanding of an individual's genetic predisposition to breast and ovarian cancers. At a cost of 7200 AED, the test represents a significant investment in personal health, empowering patients with critical information to make informed decisions about their cancer risk management.
The Hemochromatosis HFE Full Gene Sequence Analysis Test is a comprehensive genetic screening designed to detect mutations in the HFE gene, which are commonly associated with hereditary hemochromatosis. Hereditary hemochromatosis is a genetic disorder that causes the body to absorb an excessive amount of iron from the diet, leading to iron overload in various organs and tissues. If left untreated, this condition can result in significant health issues, including liver disease, heart problems, diabetes, and arthritis.
The test involves analyzing the entire gene sequence of HFE to identify mutations that may predispose an individual to developing hemochromatosis. This level of analysis can provide valuable information for individuals with a family history of the condition or those exhibiting symptoms related to iron overload.
Performed at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the Hemochromatosis HFE Full Gene Sequence Analysis Test is priced at 7200 AED. The cost reflects the comprehensive nature of the test, employing cutting-edge technology to ensure accurate and reliable results. By opting for this test, individuals can gain insights into their genetic risk for hemochromatosis, enabling them to take proactive steps in managing their health in consultation with healthcare professionals.
The Hereditary Spastic Paraplegia (HSP) Gene Panel Test is a comprehensive diagnostic tool available at DNA Labs UAE, designed to identify genetic mutations associated with Hereditary Spastic Paraplegia. HSP is a group of inherited disorders that cause progressive stiffness and weakness in the leg muscles due to the degeneration of the upper motor neurons. Given the complexity of HSP, which can be linked to mutations in various genes, this panel test screens multiple genes simultaneously to pinpoint the specific genetic alterations responsible for the condition in an individual.
Priced at 7200 AED, the test aims to offer a targeted approach in diagnosing HSP, facilitating personalized treatment plans and management strategies for affected individuals. It is particularly valuable for patients exhibiting symptoms of HSP or those with a family history of the disorder, providing crucial insights into the genetic underpinnings of their condition. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the HSP Gene Panel Test stands as a critical resource for patients and healthcare providers in the quest for accurate diagnosis and effective management of Hereditary Spastic Paraplegia.
